Advertisement

The European Union CREATE Project: A model for international standardization of allergy diagnostics and vaccines

Published:September 02, 2008DOI:https://doi.org/10.1016/j.jaci.2008.07.030
      Allergen measurements are used extensively in the formulation of allergy diagnostics and vaccines, yet no purified international allergen standards are available for calibration purposes. The aims of the European Union CREATE project were to develop international standards with verifiable allergen content. Purified natural and recombinant allergens were analyzed by means of SDS-PAGE, mass spectrometry, circular dichroism spectra, and small-angle x-ray scattering. IgE reactivity was assessed by means of direct RAST, RAST inhibition, immunoblotting, and basophil histamine release with sera from 961 allergic patients. Three recombinant allergens, rBet v 1, rPhl p 5a, and rDer p 2, were structurally indistinguishable from their natural counterparts and showed excellent IgE reactivity suitable for use as certified reference materials. A second tier of allergens (rPhl p 5b, rOle e1, rDer p 1, rDer f 1, and rDer f 2) was identified that could provide suitable candidates for certified reference materials with minor improvements to the recombinant proteins. Only rPhl p 1 was considered unsuitable as a reference material. Quantitative ELISAs were identified that accurately measured each allergen, except for rPhl p 1. The CREATE project has provided a major step forward in allergen standardization and provides a model for the development of a comprehensive panel of international reference preparations that will harmonize allergen measurements worldwide.

      Key words

      Abbreviations used:

      CD (Circular dichroism), CRM (Candidate reference material), ESI-QTOF-MS (Electrospray-ionization quadrupole time-of-flight mass spectrometry), GMP (Good manufacturing practice), SAXS (Small-angle x-ray scattering), WHO (World Health Organization)
      To read this article in full you will need to make a payment

      References

        • Bousquet J.
        • Lockey R.
        • Malling H.J.
        Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.
        J Allergy Clin Immunol. 1998; 102: 558-562
        • Nelson H.S.
        Allergen immunotherapy: where is it now?.
        J Allergy Clin Immunol. 2007; 119: 769-779
        • van Ree R.
        Indoor allergens: relevance of major allergen measurements and standardization.
        J Allergy Clin Immunol. 2007; 119: 270-277
        • Scheiner O.
        • Breiteneder H.
        • Dolocek C.
        • Duchene M.
        • Ebner C.
        • Ferreira F.
        • et al.
        Molecular and functional characterization of allergens: basic and practical aspects.
        Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 1994; 87: 221-232
        • Chapman M.D.
        • Smith A.M.
        • Vailes L.D.
        • Arruda L.K.
        • Dhanaraj V.
        • Pomés A.
        Recombinant allergens for diagnosis and therapy of allergic disease.
        J Allergy Clin Immunol. 2000; 106: 409-418
        • Becker W.M.
        • Vogel L.
        • Vieths S.
        Standardization of allergen extracts for immunotherapy: where do we stand?.
        Curr Opin Allergy Clin Immunol. 2006; 6: 470-475
        • Platts-Mills T.A.
        • Vervloet D.
        • Thomas W.R.
        • Aalberse R.C.
        • Chapman M.D.
        Indoor allergens and asthma: report of the Third International Workshop.
        J Allergy Clin Immunol. 1997; 100: S2-S24
        • Sporik R.
        • Squillace S.P.
        • Ingram J.M.
        • Rakes G.
        • Honsinger R.W.
        • Platts-Mills T.A.
        Mite, cat, and cockroach exposure, allergen sensitisation, and asthma in children: a case-control study of three schools.
        Thorax. 1999; 54: 675-680
        • Arbes Jr., S.J.
        • Cohn R.D.
        • Yin M.
        • Muilenberg M.L.
        • Burge H.A.
        • Friedman W.
        • et al.
        House dust mite allergen in US beds: results from the First National Survey of Lead and Allergens in Housing.
        J Allergy Clin Immunol. 2003; 111: 408-414
        • Sears M.R.
        • Greene J.M.
        • Willan A.R.
        • Wiecek E.M.
        • Taylor D.R.
        • Flannery E.M.
        • et al.
        A longitudinal, population-based, cohort study of childhood asthma followed to adulthood.
        N Engl J Med. 2003; 349: 1414-1422
        • Woodcock A.
        • Lowe L.A.
        • Murray C.S.
        • Simpson B.M.
        • Pipis S.D.
        • Kissen P.
        • et al.
        Early life environmental control: effect on symptoms, sensitization, and lung function at age 3 years.
        Am J Respir Crit Care Med. 2004; 170: 433-439
        • Zock J.P.
        • Heinrich J.
        • Jarvis D.
        • Verlato G.
        • Norback D.
        • Plana E.
        • et al.
        Distribution and determinants of house dust mite allergens in Europe: the European Community Respiratory Health Survey II.
        J Allergy Clin Immunol. 2006; 118: 682-690
        • Heinrich J.
        • Bedada G.B.
        • Zock J.P.
        • Chinn S.
        • Norback D.
        • Olivieri M.
        • et al.
        Cat allergen level: its determinants and relationship to specific IgE to cat across European centers.
        J Allergy Clin Immunol. 2006; 118: 674-681
        • Illi S.
        • von M.E.
        • Lau S.
        • Niggemann B.
        • Gruber C.
        • Wahn U.
        Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study.
        Lancet. 2006; 368: 763-770
        • Platts-Mills T.A.
        • Vaughan J.W.
        • Carter M.C.
        • Woodfolk J.A.
        The role of intervention in established allergy: avoidance of indoor allergens in the treatment of chronic allergic disease.
        J Allergy Clin Immunol. 2000; 106: 787-804
        • Morgan W.J.
        • Crain E.F.
        • Gruchalla R.S.
        • O'Connor G.T.
        • Kattan M.
        • Evans III, R.
        • et al.
        Results of a home-based environmental intervention among urban children with asthma.
        N Engl J Med. 2004; 351: 1068-1080
        • Platts-Mills T.A.
        • Chapman M.D.
        Allergen standardization.
        J Allergy Clin Immunol. 1991; 87: 621-625
        • Bousquet J.
        • Lockey R.
        • Malling H.J.
        • varez-Cuesta E.
        • Canonica G.W.
        • Chapman M.D.
        • et al.
        Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology.
        Ann Allergy Asthma Immunol. 1998; 81: 401-405
        • American Academy of Allergy Asthma and Immunology
        Position Statement. The use of standardized allergen extracts.
        J Allergy Clin Immunol. 2007; 99: 583-586
        • van Ree R.
        A new start for allergen references and standardization based on purified/recombinant allergens and monoclonal and monospecific polyclonal antibodies.
        in: Kurth R. Haustein D. Regulatory control and standardization of allergenic extracts. GIT VERLAG GMBH, Darmstadt (Germany)2007: 87-92
        • van Ree R.
        • Chapman M.D.
        • Ferreira F.
        • Vieths S.
        • Bryan D.
        • Cromwell O.
        • et al.
        The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification.
        Allergy. 2008; 63: 310-326
        • Reinders J.
        • Lewandrowski U.
        • Moebius J.
        • Wagner Y.
        • Sickmann A.
        Challenges in mass spectrometry-based proteomics.
        Proteomics. 2004; 4: 3686-3703
        • Geerlof A.
        • Brown J.
        • Coutard B.
        • Egloff M.P.
        • Enguita F.J.
        • Fogg M.J.
        • et al.
        The impact of protein characterization in structural proteomics.
        Acta Crystallogr D Biol Crystallogr. 2006; 62: 1125-1136
        • Verdino P.
        • Keller W.
        Circular dichroism analysis of allergens.
        Methods. 2004; 32: 241-248
        • Aalberse R.C.
        • Koshte V.
        • Clemens J.G.
        Immunoglobulin E antibodies that crossreact with vegetable foods, pollen, and Hymenoptera venom.
        J Allergy Clin Immunol. 1981; 68: 356-364
        • Kleine B.
        • I
        • de Heer P.G.
        • van der Zee J.S.
        • Aalberse R.C.
        The stripped basophil histamine release bioassay as a tool for the detection of allergen-specific IgE in serum.
        Int Arch Allergy Immunol. 2001; 126: 277-285
        • Takai T.
        • Kato T.
        • Yasueda H.
        • Okumura K.
        • Ogawa H.
        Analysis of the structure and allergenicity of recombinant pro- and mature Der p 1 and Der f 1: major conformational IgE epitopes blocked by prodomains.
        J Allergy Clin Immunol. 2005; 115: 555-563
        • Jutel M.
        • Jaeger L.
        • Suck R.
        • Meyer H.
        • Fiebig H.
        • Cromwell O.
        Allergen-specific immunotherapy with recombinant grass pollen allergens.
        J Allergy Clin Immunol. 2005; 116: 608-613
        • Suck R.
        • Kamionka T.
        • Schaffer B.
        • Wahl R.
        • Nandy A.
        • Weber B.
        • et al.
        Bacterially expressed and optimized recombinant Phl p 1 is immunobiochemically equivalent to natural Phl p 1.
        Biochim Biophys Acta. 2006; 1764: 1701-1709
        • Chapman M.D.
        • Pomés A.
        • Breiteneder H.
        • Ferreira F.
        Nomenclature and structural biology of allergens.
        J Allergy Clin Immunol. 2007; 119: 414-420
        • Batard T.
        • Didierlaurent A.
        • Chabre H.
        • Mothes N.
        • Bussieres L.
        • Bohle B.
        • et al.
        Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy.
        Int Arch Allergy Immunol. 2005; 136: 239-249